Accessibility Menu
Health Catalyst logo

Health Catalyst(NASDAQ) HCAT

Market Cap$168.48MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-94%
5 Year-96%
1 Year-37%
1 Month+10%
$2.35
+3.07%
+0.07Today
Health Catalyst last closing stock price
MetricPriceDate
Last closeUSD 2.282026-08-04
Health Catalyst stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+6.54%USD 2.142026-07-28
1 month+9.62%USD 2.082026-07-02
3 month+45.22%USD 1.572026-05-06
Year to date-4.6%USD 2.392025-12-31
1 year-37.19%USD 3.632025-08-04
3 year-83.5%USD 13.822023-08-04
5 year-95.99%USD 56.892021-08-05
Since inception-94.18%USD 39.172019-07-25

Health Catalyst Financials at a Glance

Market Cap

$168.48MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$302.48M

Net Income (TTM)

-$265.26M

EPS (TTM)

-$3.72

P/E Ratio

-0.61

Dividend

$0.00

Beta (Volatility)

1.67 (High)

Price

$2.35

Volume

632,187.308

Open

$2.30

Previous Close

$2.28

Daily Range

$2.25 - $2.35

52-Week Range

$0.96 - $3.88

Estimated Earnings Date

Aug 6, 2026

HCAT: Motley Fool Moneyball Superscore

42

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Health Catalyst

Health Catalyst enhances healthcare data management and analytics, improving clinical and financial outcomes.

Products and Services

Ignite Platform: Cloud-based data integration and analytics for healthcare.

Clinical Improvement: Tools to enhance patient care and safety.

Revenue & Cost Improvement: Solutions for financial efficiency in healthcare.

Ambulatory Operations: Streamlines outpatient care processes.

Measures & Registries: Tracks healthcare performance metrics.

Data & Analytics Services: Expert support for data-driven decisions.

Growth and Expansion

Entered international markets like Singapore and the UK in recent years.

Developed new products and expanded client base globally.

Acquired companies such as Medicity, Able Health, and Healthfinch to enhance offerings.

What Makes Health Catalyst Special

Health Catalyst's platform is tailored for healthcare, integrating data and analytics for measurable improvements. Its collaborative culture and industry recognition, such as from KLAS, highlight its commitment to customer satisfaction. The company's global reach and strategic acquisitions strengthen its market position.

Financial Highlights

Market cap: $369.0M as of June 30, 2024.

Revenue growth driven by international expansion and new product lines.

Increased client base in key markets like the UK and Singapore.

Strategic acquisitions have bolstered financial performance and market presence.

Bottom Line

Health Catalyst has evolved through strategic acquisitions and global expansion. Its focus on healthcare-specific solutions positions it as a key player in the industry.

AI Generated • Apr 16, 2026

Industry

Health Care Technology

Employees

1,200

CEO

Benjamin Albert, MBA

Headquarters

South Jordan, UT 84095, US

HCAT Financials

Key Financial Metrics (TTM)

Gross Margin

45.99%

Operating Margin

-19.20%

Net Income Margin

-87.69%

Return on Equity

-99.78%

Return on Capital

-8.66%

Return on Assets

-64.35%

Earnings Yield

-1.64%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$168.48MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

73.89M

Volume

632.19K

Avg. Volume

1.50M

Financials (TTM)

Gross Profit

$139.10M

Operating Income

-$58.09M

EBITDA

-$192.37M

Operating Cash Flow

$18.96M

Capital Expenditure

-$9.79M

Free Cash Flow

$9.17M

Cash & ST Invst.

$108.82M

Total Debt

$170.58M

Health Catalyst Performance Analysis

Health Catalyst annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 276,236,00014.2%
20232023-12-31USD 295,938,0007.1%
20242024-12-31USD 306,584,0003.6%
20252025-12-31USD 311,136,0001.5%
Health Catalyst sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-301.6%
Q32025-09-30-5.4%
Q42025-12-31-2.2%
Q12026-03-31-5.3%
Health Catalyst annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -2.63-18.6%
20232023-12-31USD -2.09-20.3%
20242024-12-31USD -1.15-44.9%
20252025-12-31USD -2.55120.5%
Health Catalyst sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-68.6%
Q32025-09-3045.8%
Q42025-12-31-300.0%
Q12026-03-31-19.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$70.76M

-10.9%

Gross Profit

$23.66M

-34.7%

Gross Margin

33.43%

N/A

Market Cap

$168.48MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$140.40K

N/A

Employees

1,200

N/A

Net Income

-$111.03M

-367.6%

EBITDA

-$93.76M

-2309.5%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$108.82M

-68.2%

Total Debt

$170.58M

-57.6%

Accounts Receivable

$59.15M

-7.7%

Inventory

$0.00

N/A

Long Term Debt

$165.22M

-1.1%

Short Term Debt

$5.36M

-97.7%

Return on Assets

-64.35%

N/A

Return on Invested Capital

-19.07%

N/A

Free Cash Flow

$13.57M

+3579.2%

Operating Cash Flow

$18.51M

+6511.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TNYATenaya Therapeutics, Inc.
$0.79+6.97%
CRBUCaribou Biosciences, Inc.
$1.60+1.59%
PYXSPyxis Oncology, Inc.
$3.09-2.22%
HSDTSolana Company
$1.73+4.22%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$110.18-0.12%
NVDANvidia
$221.92+0.05%
ONDSOndas
$8.84-0.00%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.81-0.03%

Questions About HCAT

What is the current price of Health Catalyst?

Health Catalyst is trading at $2.35 per share.

What is the 52-week range for Health Catalyst?

Over the past 52 weeks, Health Catalyst has traded between $0.96 and $3.88.

How much debt does Health Catalyst have?

As of the most recent reporting period, Health Catalyst reported total debt of $170.58M.

How much cash does Health Catalyst have on hand?

Health Catalyst reported $59.86M in cash and cash equivalents in its most recent financial results.

What is Health Catalyst’s dividend yield?

Health Catalyst does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.